Publish date: 24 November 2023
Improving outcomes for people with UGI cancers
Improving outcomes for people with upper gastrointestinal (UGI) cancers was the focus of an educational event which saw West Yorkshire and Harrogate Cancer Alliance come together with stakeholders and clinicians from across the region.
The event, held in Leeds, saw experts gathering to discuss how diagnosis and treatment for people with cancers such as pancreatic, stomach and oesophagus can be improved.
Topics under discussion included:
- Pressurised Intra-Peritoneal Aerosolised Chemotherapy (PIPAC) – a new way of delivering chemotherapy into the abdominal cavity using laparoscopic surgery for cancers of the stomach, colon and ovary
- Update on evolving landscape of treatments in UGI cancers and clinical trials
- Diagnose of common ‘lumps and bumps’ in the upper GI tract
- Robotics and its potential use in UGI resectional surgery
The event was organised by the Cancer Alliance’s Upper GI Optimal Pathway Group (OPG).
There are ten OPGs for specific tumour sites and, through effective partnership working, they aim to ensure co-ordination and reduce unwarranted variation in outcomes - from prevention to diagnosis and treatment, to living with and beyond cancer.
They work to identify and deliver consistency of clinical practice to achieve the best possible outcomes and experience for patients living with and beyond cancer in the West Yorkshire and Harrogate, irrespective of where they live and where their treatment and care is provided.
Research, education, and development are a crucial part of OPGs, with educational events held regularly.
Ends
